Cannabidiol and Metabolic Syndrome

Studies and peer-reviewed research into the effects of CBD and Metabolic Syndrome

[The potential use of cannabidiol in the therapy of metabolic syndrome].From the abstract:
It may also be effective in fighting ischaemic diseases, the most harmful complications of metabolic syndrome. However, it can only be administered as an adjuvant therapy because of its low binding potency, and its inhibiting effect of cytochrome P450 enzymes should also be considered. Nevertheless, it may be beneficially used in adjuvant therapy because of its few side effects.
Cannabinoids and endocannabinoids in metabolic disorders with focus on diabetes.From the abstract:
On the other hand, evidence is emerging that some nonpsychotropic plant cannabinoids, such as cannabidiol, can be employed to retard β-cell damage in type 1 diabetes. These novel aspects of endocannabinoid research are reviewed in this chapter, with emphasis on the biological effects of plant cannabinoids and endocannabinoid receptor antagonists in diabetes.

© 2020 CBDCOAs. All rights reserved.